These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 7584794)

  • 1. Fibrinogen and cardiovascular risk.
    Heinrich J; Assmann G
    J Cardiovasc Risk; 1995 Jun; 2(3):197-205. PubMed ID: 7584794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction--the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction.
    Scarabin PY; Aillaud MF; Amouyel P; Evans A; Luc G; Ferrières J; Arveiler D; Juhan-Vague I
    Thromb Haemost; 1998 Nov; 80(5):749-56. PubMed ID: 9843166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fibrinogen and atherothrombosis: vulnerable plaque or vulnerable patient?].
    Jaeger BR; Labarrere CA
    Herz; 2003 Sep; 28(6):530-8. PubMed ID: 14569394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inter-relationships of plasma fibrinogen, low-density lipoprotein cholesterol, cigarette smoking and the prevalence of cardiovascular disease.
    Fowkes FG; Lee AJ; Lowe GD; Riemersma RA; Housley E
    J Cardiovasc Risk; 1996 Jun; 3(3):307-11. PubMed ID: 8863104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinogen and cardiovascular disorders.
    Lip GY
    QJM; 1995 Mar; 88(3):155-65. PubMed ID: 7767665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrinogen as a cardiovascular risk factor--interrelationship with infections and inflammation.
    Ernst E
    Eur Heart J; 1993 Dec; 14 Suppl K():82-7. PubMed ID: 8131795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinogen as a risk factor for coronary heart disease.
    Montalescot G; Collet JP; Choussat R; Thomas D
    Eur Heart J; 1998 Jul; 19 Suppl H():H11-7. PubMed ID: 9717059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood rheology, cardiovascular risk factors, and cardiovascular disease: the West of Scotland Coronary Prevention Study.
    Lowe G; Rumley A; Norrie J; Ford I; Shepherd J; Cobbe S; Macfarlane P; Packard C
    Thromb Haemost; 2000 Oct; 84(4):553-8. PubMed ID: 11057849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemorheological, platelet and endothelial indices in relation to global measures of cardiovascular risk in hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
    Spencer CG; Felmeden DC; Blann AD; Lip GY
    J Intern Med; 2007 Jan; 261(1):82-90. PubMed ID: 17222171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemostatic variables in the prediction of coronary risk: results of the 8 year follow-up of healthy men in the Münster Heart Study (PROCAM). Prospective Cardiovascular Münster Study.
    Assmann G; Cullen P; Heinrich J; Schulte H
    Isr J Med Sci; 1996 Jun; 32(6):364-70. PubMed ID: 8682642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fibrinogen, a vascular risk factor].
    Caen JP; Soria J; Collet JP; Soria C
    Bull Acad Natl Med; 1993 Nov; 177(8):1433-41; discussion 1441-4. PubMed ID: 8193948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of obesity-associated cardiovascular disease is related to inflammation-sensitive plasma proteins: a population-based cohort study.
    Engström G; Hedblad B; Stavenow L; Jonsson S; Lind P; Janzon L; Lindgärde F
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1498-502. PubMed ID: 15178569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
    Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma viscosity and related cardiovascular risk factors in a Spanish Mediterranean population.
    Vayá A; Simó M; Santaolaria M; Carrasco P; Corella D
    Thromb Res; 2007; 120(4):489-95. PubMed ID: 17215030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Plasma fibrinogen and cardiovascular disease].
    Møller LF; Jespersen J; Kristensen TS
    Ugeskr Laeger; 1991 Aug; 153(34):2343-5. PubMed ID: 1897044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fibrinogen as a cardiovascular risk factor--marker or causal factor?].
    Halvorsen S
    Tidsskr Nor Laegeforen; 1999 Aug; 119(19):2829-32. PubMed ID: 10494205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement C3 and C4 in plasma and incidence of myocardial infarction and stroke: a population-based cohort study.
    Engström G; Hedblad B; Janzon L; Lindgärde F
    Eur J Cardiovasc Prev Rehabil; 2007 Jun; 14(3):392-7. PubMed ID: 17568238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of molsidomine on rheological parameters and the incidence of cardiovascular events].
    Wöhrle J; Nusser T; Hoffmeister A; Kestler HA; Grebe OC; Höher M; Hombach V; Koenig W; Kochs M
    Dtsch Med Wochenschr; 2003 Jun; 128(24):1333-7. PubMed ID: 12802741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrinogen: its role in the hemostatic regulation in atherosclerosis.
    Eber B; Schumacher M
    Semin Thromb Hemost; 1993; 19(2):104-7. PubMed ID: 8356454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma heparin cofactor II activity is an independent predictor of future cardiovascular events in patients after acute myocardial infarction.
    Huang SS; Huang PH; Chen YH; Sung SH; Chiang KH; Chen JW; Lin SJ
    Coron Artery Dis; 2008 Dec; 19(8):597-602. PubMed ID: 18971786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.